DEVON KNEISEL: Open Payments
NPI 1033977145 · NORTH RICHLAND HILLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 24 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $311 · 2025 $546
Food & beverage: $462Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $165 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $121 |
| Novo Nordisk Inc | 3 | $59 |
| ABBVIE INC. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Lilly USA, LLC | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $20 |
| VIVUS LLC | 1 | $19 |
| Corcept Therapeutics | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
Products named: TREMFYA, XIFAXAN, RINVOQ, Wegovy, ENTYVIO, MOUNJARO, NP Thyroid 60, PANCREAZE.
Industry payments across TX — which companies pay providers there.
